The p-traps of hospital handwashing sinks represent a potential reservoir for antimicrobial-resistant organisms of major public health concern, such as carbapenemase-producing KPC+ Klebsiella pneumoniae (CPKP). Bacteriophages have reemerged as potential biocontrol agents, particularly against biofilm-associated, drug-resistant microorganisms. The primary objective of our study was to formulate a phage cocktail capable of targeting a CPKP strain (CAV1016) at different stages of colonization within polymicrobial drinking water biofilms using a CDC biofilm reactor (CBR) p-trap model. A cocktail of four CAV1016 phages, all exhibiting depolymerase activity, were isolated from untreated wastewater using standard methods. Biofilms containing Pseudomonas aeruginosa, Micrococcus luteus, Stenotrophomonas maltophilia, Elizabethkingia anophelis, Cupriavidus metallidurans, and Methylobacterium fujisawaense were established in the CBR p-trap model for a period of 28 d. Subsequently, CAV1016 was inoculated into the p-trap model and monitored over a period of 21 d. Biofilms were treated for 2 h at either 25 °C or 37 °C with the phage cocktail (109 PFU/ml) at 7, 14, and 21 d post-inoculation. The effect of phage treatment on the viability of biofilm-associated CAV1016 was determined by plate count on m-Endo LES agar. Biofilm heterotrophic plate counts (HPC) were determined using R2A agar. Phage titers were determined by plaque assay. Phage treatment reduced biofilm-associated CAV1016 viability by 1 log10 CFU/cm2 (p < 0.05) at 7 and 14 d (37 °C) and 1.4 log10 and 1.6 log10 CFU/cm2 (p < 0.05) at 7 and 14 d, respectively (25 °C). No significant reduction was observed at 21 d post-inoculation. Phage treatment had no significant effect on the biofilm HPCs (p > 0.05) at any time point or temperature. Supplementation with a non-ionic surfactant appears to enhance phage association within biofilms. The results of this study suggest the potential of phages to control CPKP and other carbapenemase-producing organisms associated with microbial biofilms in the healthcare environment.
Citation: Ariel J. Santiago, Maria L. Burgos-Garay, Leila Kartforosh, Mustafa Mazher, Rodney M. Donlan. Bacteriophage treatment of carbapenemase-producing Klebsiella pneumoniae in a multispecies biofilm: a potential biocontrol strategy for healthcare facilities[J]. AIMS Microbiology, 2020, 6(1): 43-63. doi: 10.3934/microbiol.2020003
[1] | José Luis Díaz Palencia, Abraham Otero . Modelling the interaction of invasive-invaded species based on the general Bramson dynamics and with a density dependant diffusion and advection. Mathematical Biosciences and Engineering, 2023, 20(7): 13200-13221. doi: 10.3934/mbe.2023589 |
[2] | Peter Hinow, Philip Gerlee, Lisa J. McCawley, Vito Quaranta, Madalina Ciobanu, Shizhen Wang, Jason M. Graham, Bruce P. Ayati, Jonathan Claridge, Kristin R. Swanson, Mary Loveless, Alexander R. A. Anderson . A spatial model of tumor-host interaction: Application of chemotherapy. Mathematical Biosciences and Engineering, 2009, 6(3): 521-546. doi: 10.3934/mbe.2009.6.521 |
[3] | Maryam Basiri, Frithjof Lutscher, Abbas Moameni . Traveling waves in a free boundary problem for the spread of ecosystem engineers. Mathematical Biosciences and Engineering, 2025, 22(1): 152-184. doi: 10.3934/mbe.2025008 |
[4] | James T. Cronin, Nalin Fonseka, Jerome Goddard II, Jackson Leonard, Ratnasingham Shivaji . Modeling the effects of density dependent emigration, weak Allee effects, and matrix hostility on patch-level population persistence. Mathematical Biosciences and Engineering, 2020, 17(2): 1718-1742. doi: 10.3934/mbe.2020090 |
[5] | Lin Zhang, Yongbin Ge, Xiaojia Yang . High-accuracy positivity-preserving numerical method for Keller-Segel model. Mathematical Biosciences and Engineering, 2023, 20(5): 8601-8631. doi: 10.3934/mbe.2023378 |
[6] | Ardak Kashkynbayev, Yerlan Amanbek, Bibinur Shupeyeva, Yang Kuang . Existence of traveling wave solutions to data-driven glioblastoma multiforme growth models with density-dependent diffusion. Mathematical Biosciences and Engineering, 2020, 17(6): 7234-7247. doi: 10.3934/mbe.2020371 |
[7] | Blessing O. Emerenini, Stefanie Sonner, Hermann J. Eberl . Mathematical analysis of a quorum sensing induced biofilm dispersal model and numerical simulation of hollowing effects. Mathematical Biosciences and Engineering, 2017, 14(3): 625-653. doi: 10.3934/mbe.2017036 |
[8] | Chichia Chiu, Jui-Ling Yu . An optimal adaptive time-stepping scheme for solving reaction-diffusion-chemotaxis systems. Mathematical Biosciences and Engineering, 2007, 4(2): 187-203. doi: 10.3934/mbe.2007.4.187 |
[9] | Maher Alwuthaynani, Raluca Eftimie, Dumitru Trucu . Inverse problem approaches for mutation laws in heterogeneous tumours with local and nonlocal dynamics. Mathematical Biosciences and Engineering, 2022, 19(4): 3720-3747. doi: 10.3934/mbe.2022171 |
[10] | Tracy L. Stepien, Erica M. Rutter, Yang Kuang . A data-motivated density-dependent diffusion model of in vitro glioblastoma growth. Mathematical Biosciences and Engineering, 2015, 12(6): 1157-1172. doi: 10.3934/mbe.2015.12.1157 |
The p-traps of hospital handwashing sinks represent a potential reservoir for antimicrobial-resistant organisms of major public health concern, such as carbapenemase-producing KPC+ Klebsiella pneumoniae (CPKP). Bacteriophages have reemerged as potential biocontrol agents, particularly against biofilm-associated, drug-resistant microorganisms. The primary objective of our study was to formulate a phage cocktail capable of targeting a CPKP strain (CAV1016) at different stages of colonization within polymicrobial drinking water biofilms using a CDC biofilm reactor (CBR) p-trap model. A cocktail of four CAV1016 phages, all exhibiting depolymerase activity, were isolated from untreated wastewater using standard methods. Biofilms containing Pseudomonas aeruginosa, Micrococcus luteus, Stenotrophomonas maltophilia, Elizabethkingia anophelis, Cupriavidus metallidurans, and Methylobacterium fujisawaense were established in the CBR p-trap model for a period of 28 d. Subsequently, CAV1016 was inoculated into the p-trap model and monitored over a period of 21 d. Biofilms were treated for 2 h at either 25 °C or 37 °C with the phage cocktail (109 PFU/ml) at 7, 14, and 21 d post-inoculation. The effect of phage treatment on the viability of biofilm-associated CAV1016 was determined by plate count on m-Endo LES agar. Biofilm heterotrophic plate counts (HPC) were determined using R2A agar. Phage titers were determined by plaque assay. Phage treatment reduced biofilm-associated CAV1016 viability by 1 log10 CFU/cm2 (p < 0.05) at 7 and 14 d (37 °C) and 1.4 log10 and 1.6 log10 CFU/cm2 (p < 0.05) at 7 and 14 d, respectively (25 °C). No significant reduction was observed at 21 d post-inoculation. Phage treatment had no significant effect on the biofilm HPCs (p > 0.05) at any time point or temperature. Supplementation with a non-ionic surfactant appears to enhance phage association within biofilms. The results of this study suggest the potential of phages to control CPKP and other carbapenemase-producing organisms associated with microbial biofilms in the healthcare environment.
The motion of cells moving towards the higher concentration of a chemical signal is called chemotaxis. For example, bacteria moves toward the highest concentration of food molecules to find food. A well-known chemotaxis model was initially proposed by Keller and Segel [15] in 1971, subsequently, a number of variations of the Keller-Segel system were proposed and have been extensively studied during the past four decades, for example, see the survey papers [1,12] and the references therein. Especially, chemotaxis models also appear in medical mathematics. Many factors effect the migration mechanisms of tumour cells. For example, the extracellular matrix (ECM), to which the tumour cell to be attached, inhibits the cell polarizes and elongates to migrate. ECM-degrading enzymes (MDE) cleave ECM fibers into smaller chemotactic fragments to facilitate cell-migration [6]. In [4], Chaplain and Anderson introduced a model for tumour invasion mechanism, which describes tumour invasion phenomenon in accounting for the role of chemotactic ECM fragments named ECM*, produced by a biological reaction between ECM and MDE. In these models, the tumour cell random motility is assumed to be a constant, which leads to linear isotropic diffusion. However, in realistic situation, it is emphasized that migration of the tumour cells through the ECM fibers should rather be regarded like movement in a porous medium with degenerate diffusion from a physical point of view [38]. Compared with the classical tumour invasion model with linear diffusion, the mathematical analysis of the nonlinear diffusion system has to cope with considerable additional challenges and is much less understood. Several chemotaxis models with nonlinear diffusion have been recently proposed and analyzed, e.g. [18,38,45,46], where the nonlinear diffusions in these studies were still assumed to be non-degenerate. For tumour angiogenesis model and relevant mathematical analysis with or without degenerate diffusion, we refer to [14,22,23,48,49,50,52,54] and the references therein.
Tumour cells can modify their migration mechanisms in response to different conditions [6]. There are two potentially important factors: (ⅰ) the effect of cell-density on the probability of cell movement; (ⅱ) the effect of signal-mediated cell-density sensing mechanisms on movement [28]. For interacting cell population, Painter and Sherratt [29] further presented four different sensing strategies: strictly local, neighbour based, local average and gradient. Cell movement involves the processing of multiple signals, each of them may act on the cells in different ways. For neighbor-based and gradient-based rules, Painter and Hillen [28] proposed volume filling approach, that is, the movement of cells is inhibited by the neighboring site where the cells are densely packed. Inspired by the idea of Painter et al. [28,29] and recently in Xu et al. [57], we extend Chaplain and Anderson's model [4] to a new one with density-dependent jump probability of tumour cells as follows, which is concerned with the competition between the following several biological mechanisms: degenerate diffusion, density-dependent chemotaxis, and general logistic growth. That is,
{∂u∂t=∇⋅(q(u)∇u)−∇⋅(q(u)u∇v)+μuδ(1−ru),x∈Ω,t>0,∂v∂t=Δv+wz,x∈Ω,t>0,∂w∂t=−wz,x∈Ω,t>0,∂z∂t=Δz−z+u,x∈Ω,t>0. | (1) |
The detailed derivation of the model (1) will be carried out in the Appendix. Here,
The unbiased cell movement modelled by linear diffusion motility mechanism has been used extensively to study a variety of cell biology problems. However, when cells are close enough for regular contacts, they will inevitably interact [29]. Linear diffusion of each cell type is inappropriate for the close-packed cell populations involved in early tumour growth. The degenerate nonlinear diffusion can represent ''population pressure'' in cell invasion models [29], which arises from the ecology dispersal literature [9,10,24,58]. A high cell density results in increased probability of a cell being ''pushed'' from a site. In this case, large dispersal takes place in highly populated regions, but low mobility occurs in the regions of low cell density. The cell invasions described by nonlinear degenerate systems with the density-dependent nonlinear diffusivity function
Some studies found that degenerate nonlinear diffusion model related to the porous media equation (PME) provides a better match to experimental cell density profiles [34]. Sengers and coworkers [30] developed a set of in vitro cell invasion experiments and image analysis to quantify the migration and proliferation of two different skeletal cell types, including human osteosarcoma MG63 cells and human bone marrow stromal cells (HBMSCs). Comparison of experimental and simulated cell distribution are shown in Fig. 1 in [30], where the cell density considerably increased and simultaneously spread outwards from the centre of the cell circle, producing a new cell migration front every day. Their results show that the MG63 migration with sharp front is best described by a degenerate diffusion model with the diffusivity
An interesting work related to the chemotaxis model mentioned above is [7], in which they considered the following chemotaxis system with linear diffusion
{∂u∂t=Δu−∇⋅(u∇v),x∈Ω,t>0,∂v∂t=Δv+wz,x∈Ω,t>0,∂w∂t=−wz,x∈Ω,t>0,∂z∂t=Δz−z+u,x∈Ω,t>0. | (2) |
It is proved the existence of global solutions and the asymptotic behaviors of global solutions as time goes to infinity by using the properties of the Neumann heat semigroup
Apart from the diffusive motility, another important mechanism in cell invasion is cell proliferation. In [35], an assay using gut organ culture validates that proliferation at the invading front is the critical mechanism driving apparently directed invasion. Cells at the invasive front are proliferative and migrate into previously unoccupied tissue. It also has important implications for carcinoma invasion. Tumour invasion systems with proliferative cells have been studied extensively [8,21,26]. Logistic growth is one of important models of proliferation to a carrying capacity limit [24]. Von Bertalanffy derived a general logistic growth law for avascular tumour growth [44], and suggested that
f(u)=γuλ−δuμ, |
where
Compared to the linear cases, the chemotactic system with degenerate diffusion and chemotactic sensitivity is more complex and challenging. Since the first equation of (1) is degenerate at any point where
In this paper, we provide a more realistic description of cell migration process for early and late stages. It is worth to mention that our stability results of the model (1) give a certain estimate for the speed of the expanding speed of tumour region. We construct suitable subsolutions and supersolutions to show the position of the free boundary for the tumour region. Then, we prove that there exist
A1(t)⊂suppu(⋅,t)⊂¯A2(t)⊂Ω,t∈(0,t0), |
As we all know, for linear diffusion equations with initial data
An in vivo primary tumour initially develops in epithelia and grows within the epithelium before expanding into surrounding tissues [32]. The very early stages of tumour growth are rarely seen clinically due to the small size of the cell masses. However, this early growth has been well studied in vitro using HEPA-1 tumour cells. Small aggregates of several cells formed during the initial hours in culture and accounted for the rapid increase in the mean volume of the cell spheroids. This assay was introduced by Leek [16] in 1999. Then, Owen et al. compared their numerical simulations with this experimental data. There is a good agreement between the experimental and numerical results for the outer spheroid radius [27]. Key results from their study are shown in Fig. 2. Growth was rapid for the initial days, decreased, and approached a horizontal asymptote. It can be difficult to decide what type of model is best suited to a particular biological problem. Different approaches in mathematics can reproduce the same experimental results [3]. Our theoretical results also provide a good fit to the experimental results in [16]. The shape of the growth curve of the cell spheroids is similar to the graph of power function
In contrast with the well known linear cases, the degenerate diffusion is endowed with the interesting feature of slow diffusion, that is, the compact support of solutions propagates at a finite speed. The slow diffusion feature has some advantages and accuracy for describing specified biological processes in the point of view of the physical reality, and it also leads to more challenges in the mathematical studies. For example, in order to investigate the asymptotic behavior of solutions, one must appropriately describe the propagation behavior of its support, which is more likely to be a compact subset of the prescribed domain for some time interval if the initial data are given so. We mention that the Neumann heat semigroup theory and functional transform methods have been proved to be effective in studying the global boundedness and large time behavior for the linear diffusion equations, but they are all inapplicable in the degenerate diffusion case due to the nonlinearity. We establish the global existence of bounded weak solutions to this model by energy estimate technique and methods based on Moser-type iteration. Then we prove that, at the late stage of the tumour migration, the original weak solution time-asymptotically converges to its steady state, even if the initial perturbation is large, namely, the global stability of the steady state. The adopted approach is the technical compactness analysis with the help of the comparison principle deduced by the approximate Hohmgren's approach and two kinds of lower solutions showing the expanding support and the exponentially convergence. The one is a self similar weak lower solution of Barenblatt type and the other kind is an ODE solution.
This paper is organized as follows. In Section 2, we state our main results. We leave the global existence of weak solutions to the corresponding chemotaxis system and their regularity into Section 3 as preliminaries. Section 4 is devoted to the study of compact support property of the tumour cells at early stage and the large time behavior at late stage, showing the exponentially convergence of solutions.
In this section, we first state our main results on the study of expanding compact support of the tumour cells at early stage and the asymptotic behavior at late stage. We leave the detailed derivation on the new chemotaxis model (1) with density-dependent jump probability in the Appendix. We estimate the upper bound and lower bound for expanding speed of tumour cell region at early stage (before the tumour cells spread to the whole body) and show the exponentially convergence of solutions for large time.
We consider the following system (3) with degenerate diffusion
{ut=Δ(q(u)u)−∇⋅(q(u)u∇v)+μuδ(1−u),vt=Δv+wz,wt=−wz,zt=Δz−z+u,x∈Ω,t>0,∂u∂ν=∂v∂ν=∂z∂ν=0,x∈∂Ω,t>0,u(x,0)=u0(x),v(x,0)=v0(x),w(x,0)=w0(x),z(x,0)=z0(x),x∈Ω, | (3) |
where
Since degenerate diffusion equations may not have classical solutions in general, we need to formulate the following definition of generalized solutions for the initial boundary value problem (3).
Definition 2.1. Let
(1)
(2)
(3)
(4)
(5) the identities
∫T0∫Ωuψtdxdt+∫Ωu0(x)ψ(x,0)dx=∫T0∫Ω∇(q(u)u)⋅∇ψdxdt−∫T0∫Ωq(u)u∇v⋅∇ψdxdt−∫T0∫Ωμuδ(1−u)ψdxdt,∫T0∫Ωvtφdxdt+∫T0∫Ω∇v⋅∇φdxdt=∫T0∫Ωwzφdxdt,∫T0∫Ωwtφdxdt=−∫T0∫Ωwzφdxdt,∫T0∫Ωztφdxdt+∫T0∫Ω∇z⋅∇φdxdt=∫T0∫Ω(u−z)φdxdt, |
hold for all
(6)
If
A quadruple
supt∈R+{‖u‖L∞(Ω)+‖v‖W1,∞(Ω)+‖w‖L∞(Ω)+‖z‖W1,∞(Ω)}≤C. |
Throughout this paper we assume that
u′(t)=μuδ(1−u),u(0)=u0, |
which is ill-posed if
As preliminaries, we leave the global existence and regularity results into Section 3. Our main results concerned with the description of cell invasion processes are as follows. First, we show that the evolution of tumour invasion in the very early stage.
Theorem 2.2 (Early stage profile - upper bound). Let
suppu0⊂¯Br0(x0)⊂Ω, |
for some
suppu(⋅,t)⊂¯A(t)⊂Ω,t∈(0,t1), |
and
A(t)={x∈Ω;|x−x0|2<η(τ+t)},t∈(0,t1), |
with some appropriate
Remark 1. As a typical finite propagating model, the Barenblatt solution of the porous medium equation is
B(x,t)=(1+t)−k[(1−k(m−1)2mn|x|2(1+t)2k/n)+]1m−1 | (4) |
with
Next, we show the propagating property of the tumour cells at the early stage.
Theorem 2.3 (Early stage profile - lower bound). Let
A(t)⊂suppu(⋅,t),t>0, |
and
Remark 2. For this chemotaxis system, we proved that the tumour cells will expand to the whole body when the time
Under the hypotheses of Theorem 2.2 and Theorem 2.3, we see that there exist
A1(t)⊂suppu(⋅,t)⊂¯A2(t)⊂Ω,t∈(0,t0), |
After the tumour cells spread to the whole domain, we can investigate the large time behavior. We show that the solution converges to its steady state exponentially.
Theorem 2.4 (Late stage profile). Let
‖u(⋅,t)−1‖L∞(Ω)+‖w(⋅,t)‖W1,∞(Ω)+‖v(⋅,t)−(¯v0+¯w0)‖W2,∞(Ω)+‖z(⋅,t)−1‖L∞(Ω)≤Ce−ct, |
for all
The main difficulty lies in proving the expanding property of the support of the first component
As preliminaries, we prove the existence, boundedness and regularity of a global weak solution in this section. The main preliminary results are as follows.
Theorem 3.1 (Existence of globally bounded weak solutions). For
Theorem 3.2 (Regularity). Let
‖u‖L∞(Ω×(t,t+1))+‖v‖C2+α,1+α/2(¯Ω×[t,t+1])+‖w‖Cα(¯Ω×[t,t+1])+‖z‖W2,1p(Ω×(t,t+1))≤C(p), |
for any
We first use the artificial viscosity method to get smooth approximate solutions. Despite the absence of comparison principle, we can prove a special case compared with a lower solution, which is helpful for establishing the regularity estimates. By making use of the special structure of dispersion, we carry on the estimates on
Consider the following corresponding regularized problem
{ut=∇⋅(m(aε(u))m−1∇u)−∇⋅(um∇v)+μ|u|δ−1u(1−u)+ε,vt=Δv+wz,wt=−wz,zt=Δz−z+u,x∈Ω,t>0,∂u∂ν=∂v∂ν=∂z∂ν=0,x∈∂Ω,t>0,u(x,0)=u0ε(x),v(x,0)=v0ε(x),w(x,0)=w0ε(x),z(x,0)=z0ε(x),x∈Ω, | (5) |
where
ε≤u0ε≤u0+ε,0≤v0ε≤v0+ε,0≤w0ε≤w0+ε,0≤z0ε≤z0+ε,|∇u0ε|≤2|∇u0|,|∇v0ε|≤2|∇v0|,|∇w0ε|≤2|∇w0|,|Δw0ε|≤2|Δw0|,|∇z0ε|≤2|∇z0|, |
and
As usual, there is no comparison principle for the system, because the system is strongly coupled. However, we have the following lemma.
Lemma 3.3. There holds
Proof. We denote
Now we divide this proof into two parts. If
∇⋅(m(aε(u))m−1∇u)=m(aε(u))m−1Δu+m(m−1)a′ε(u)|∇u|2≥0,∇⋅(um∇v)=umΔv+mum−1∇u⋅∇v=0,μ|u|δ−1u(1−u−w)=0, |
which contradicts to
If
Since
∂u∂t=Δ(u+ε)m−∇⋅(um∇v)+μuδ(1−u)+ε,u≥0. |
Now we present some energy estimates independent of time
Lemma 3.4. The first solution component
supt∈(0,Tmax)∫Ωuε(⋅,t)dx≤max{∫Ωu0dx+|Ω|,(2(C1+|Ω|)μC2)1/(δ+1)}, |
where
Proof. We denote
ddt∫Ωudx≤μ∫Ωuδdx−μ∫Ωuδ+1dx+|Ω|, |
for all
μ∫Ωuδdx≤12μ∫Ωuδ+1dx+C1, |
and
∫Ωuδ+1dx≥C2(∫Ωudx)δ+1, |
where
y′(t)≤C1+|Ω|−μC22yδ+1(t). |
The comparison principle of ODE shows that
y(t)≤max{y(0),(2(C1+|Ω|)μC2)1/δ+1} |
for all
Here we recall some lemmas about the
Lemma 3.5 ([7]). Let
{q∈[1,npn−2p),p≤n2,q∈[1,∞],p>n2. |
Then for any
supt∈(0,T)‖zε(⋅,t)‖Lq(Ω)≤Cz(p,q)(‖z0‖Lq(Ω)+supt∈(0,T)‖uε(⋅,t)‖Lp(Ω)). |
Lemma 3.6 ([7]). Let
{r∈[1,nqn−q),q≤n,r∈[1,∞],q>n. |
Then for any
supt∈(0,T)‖∇vε(⋅,t)‖Lr(Ω)≤Cv(q,r)(‖∇v0‖Lr(Ω)+supt∈(0,T)‖zε(⋅,t)‖Lq(Ω)). |
Lemma 3.7. There holds
‖wε(⋅,t)‖L∞(Ω)≤‖w0‖L∞(Ω)+1,t∈(0,Tmax), |
and
∫Ωvε(x,t)dx≤∫Ωv0(x)dx+∫Ωw0(x)dx+2|Ω|,t∈(0,Tmax). |
Proof. Since both
|wε(x,t)|≤w0ε(x,t)≤‖w0‖L∞(Ω)+1. |
We add the third to the second equation of (5) and integrate over
ddt∫Ω(vε+wε)dx=∫ΩΔvεdx=0,t∈(0,Tmax). |
Thus,
∫Ω(vε+wε)dx≤∫Ωv0ε(x)dx+∫Ωw0ε(x)dx≤∫Ωv0(x)dx+∫Ωw0(x)dx+2|Ω|, |
for all
Lemma 3.8. Let
‖vε‖L∞(Ω)≤C,t∈(0,Tmax). |
For any
‖∇vε‖Lr(Ω)≤C(r),t∈(0,Tmax). |
Proof. According to Lemma 3.4,
The following Gagliardo-Nirenberg inequality (see [46,51]) will be used in deriving the
Lemma 3.9. Let
‖u‖Lp(Ω)≤C(‖∇u‖aL2(Ω)‖u‖1−aLs(Ω)+‖u‖Ls(Ω)) |
is valid with
We present the following
Lemma 3.10. Let
‖uε(⋅,t)‖Lp(Ω)≤C(p),t∈(0,Tmax). |
Proof. We denote
1r+1ddt∫Ωur+1dx+∫Ω∇(u+ε)m⋅∇urdx≤∫Ωum∇v⋅∇urdx+μ∫Ωuδ+rdx−μ∫Ωuδ+r+1dx+∫Ωurdx. | (6) |
We note that
μ∫Ωuδ+rdx≤14μ∫Ωuδ+r+1dx+C1, | (7) |
and
∫Ωurdx≤14μ∫Ωuδ+r+1dx+C2, | (8) |
where
∫Ωum∇v⋅∇urdx≤r∫Ωum+r−1|∇v⋅∇u|dx≤mr2∫Ω(u+ε)m−1ur−1|∇u|2dx+r2m∫Ωum+r|∇v|2dx≤12∫Ω∇(u+ε)m⋅∇urdx+r2m∫Ωum+r|∇v|2dx. | (9) |
We use Hölder's inequality to see that
r2m∫Ωum+r|∇v|2dx≤r2m(∫Ωum+r+κdx)m+rm+r+κ(∫Ω|∇v|2(m+r+κ)κdx)κm+r+κ≤C3(∫Ωum+r+κdx)m+rm+r+κ |
where
(∫Ωum+r+κdx)m+rm+r+κ=‖um+r2‖2L2(m+r+κ)m+r(Ω)≤C4(‖∇um+r2‖2aL2(Ω)‖um+r2‖2(1−a)L2m+r(Ω)+‖um+r2‖2L2m+r(Ω))≤C5(1+‖∇um+r2‖2aL2(Ω)), |
where
a=n(m+r)/2−n(m+r)/(2(m+r+κ))1−n/2+n(m+r)/2∈(0,1), |
provided that
r2m∫Ωum+r|∇v|2dx≤C3C5(1+‖∇um+r2‖2aL2(Ω))≤2mr(m+r)2‖∇um+r2‖2L2(Ω)+C6≤mr2∫Ω(u+ε)m−1ur−1|∇u|2dx+C6≤12∫Ω∇(u+ε)m⋅∇urdx+C6, | (10) |
since
ddt∫Ωur+1dx≤−μ(r+1)2∫Ωuδ+r+1dx+(r+1)(C1+C2+C6). |
According to
∫Ωuδ+r+1dx≥1|Ω|δr+1(∫Ωur+1dx)δ+r+1r+1, |
we obtain
ddt∫Ωur+1dx≤(r+1)(C1+C2+C6)−μ(r+1)2|Ω|δr+1(∫Ωur+1dx)δ+r+1r+1. |
By an ODE comparison,
∫Ωur+1dx≤max{∫Ω(u0+1)r+1dx,(2(C1+C2+C6)|Ω|δr+1μ)r+1δ+r+1} |
for all
Lemma 3.11. Let
supt∈(0,Tmax)‖∇vε‖L∞(Ω)≤C. |
Proof. According to Lemma 3.10,
We now employ the following Moser-type iteration to get the
Lemma 3.12. Let
supt∈(0,Tmax)‖uε‖L∞(Ω)≤C. |
Proof. We denote
1r+1ddt∫Ωur+1dx+∫Ω∇(u+ε)m⋅∇urdx≤∫Ωum∇v⋅∇urdx+μ∫Ωuδ+rdx−μ∫Ωuδ+r+1dx+∫Ωurdx. | (11) |
Similar to the proof of Lemma 3.10, using Young's inequality we can estimate
μ∫Ωuδ+rdx≤14μ∫Ωuδ+r+1dx+4δ+rμ|Ω|,∫Ωurdx≤14μ∫Ωuδ+r+1dx+(4μ)rδ+r|Ω|, |
and
∫Ωum∇v⋅∇urdx≤r∫Ωum+r−1|∇v⋅∇u|dx≤mr4∫Ω(u+ε)m−1ur−1|∇u|2dx+rm∫Ωum+r|∇v|2dx≤14∫Ω∇(u+ε)m⋅∇urdx+rm‖∇v‖2L∞(Ω)∫Ωum+rdx, | (12) |
where according to Lemma 3.11
∫Ωum+rdx=‖um+r2‖2L2(Ω)≤C0(‖∇um+r2‖2aL2(Ω)‖um+r2‖2(1−a)L1(Ω)+‖um+r2‖2L1(Ω)), |
where
rm‖∇v‖2L∞(Ω)∫Ωum+rdx≤rm‖∇v‖2L∞(Ω)C0(‖∇um+r2‖2aL2(Ω)‖um+r2‖2(1−a)L1(Ω)+‖um+r2‖2L1(Ω))≤mr(m+r)2‖∇um+r2‖2L2(Ω)+(rm‖∇v‖2L∞(Ω)C0)11−a((m+r)2mr)a1−a‖um+r2‖2L1(Ω)+rm‖∇v‖2L∞(Ω)C0‖um+r2‖2L1(Ω)≤14∫Ω∇(u+ε)m⋅∇urdx+C1(r)‖um+r2‖2L1(Ω), | (13) |
where
C1(r)=(rm‖∇v‖2L∞(Ω)C0)11−a((m+r)2mr)a1−a+rm‖∇v‖2L∞(Ω)C0. |
Inserting the above estimates (12), (13) into (11) yields
ddt∫Ωur+1dx+∫Ωur+1dx≤C1(r)(r+1)‖um+r2‖2L1(Ω)+(r+1)(4δ+rμ|Ω|+(4μ)rδ+r|Ω|)+∫Ωur+1dx−12μ∫Ωuδ+r+1dx≤C1(r)(r+1)‖um+r2‖2L1(Ω)+C2(r), | (14) |
where
C2(r)=(r+1)(4δ+rμ|Ω|+(4μ)rδ+r|Ω|)+(2μ)r+1δ|Ω|. |
Now we use the following Moser-type iteration. Let
rj−1+1=rj+m2,j∈N+. |
We can invoke Lemma 3.10 to find
supt∈(0,Tmax)‖u‖Lr1+1(Ω)≤C0. |
From (14) and an ODE comparison, we have
supt∈(0,Tmax)‖u‖rj+1Lrj+1(Ω)≤max{∫Ω(u0+1)rj+1dx,C1(rj)(rj+1)⋅supt∈(0,Tmax)‖u‖2(rj−1+1)Lrj−1+1(Ω)+C2(rj)}. | (15) |
A simple analysis shows that
supt∈(0,Tmax)‖u‖rj+1Lrj+1(Ω)≤max{∫Ω(u0+1)rj+1dx,a1rb1j⋅supt∈(0,Tmax)‖u‖2(rj−1+1)Lrj−1+1(Ω)+a2brj2}. | (16) |
Let
Mj=max{supt∈(0,Tmax)∫Ωurj+1dx,1}. |
Since boundedness of
Mj≤a1rb1jM2j−1+a2brj2. | (17) |
We note that if
M1rj−1+1j−1≤(a2brj2)12(rj−1+1)≤a1rj+m2brjrj+m2≤2b2, |
for
M2j−1≥a2brj2,j≥j0. |
Therefore, we can rewrite (17) into
Mj≤2a1rb1jM2j−1≤DjM2j−1 | (18) |
for all
Mj≤D∑j−2i=0(j−i)⋅2j⋅M2j−11=D2j+2j−1−j−2M2j−11≤D2j+1M2j−11 |
for all
M1rj+1j≤D2j+12j+m−1M2j−12j+m−10≤D2M1, |
for all
Now we turn to the regularity estimates.
Lemma 3.13. Let
supt∈(0,Tmax)(‖zε‖L∞(Ω)+‖∇zε‖L∞(Ω)+‖vε‖L∞(Ω)+‖∇vε‖L∞(Ω))≤C. |
And the third solution component
‖∇wε(⋅,t)‖L∞(Ω)≤2‖∇w0‖L∞(Ω)+(‖w0‖L∞(Ω)+1)supt∈(0,Tmax)‖∇zε‖L∞(Ω)t, |
for all
Proof. According to Lemma 3.12, Lemma 3.5, Lemma 3.6, we see that
w(x,t)=w0ε(x)e−∫t0z(x,τ)dτ,∇w(x,t)=∇w0ε(x)e−∫t0z(x,τ)dτ−w0ε(x)e−∫t0z(x,τ)dτ∫t0∇z(x,τ)dτ. |
Therefore,
|∇w(x,t)|≤|∇w0ε(x,t)|+w0ε(x)supt∈(0,Tmax)‖∇z‖L∞(Ω)t≤2‖∇w0‖L∞(Ω)+(‖w0‖L∞(Ω)+1)supt∈(0,Tmax)‖∇zε‖L∞(Ω)t. |
This completes the proof.
Lemma 3.14. There exists a constant
∫T0∫Ω|Δvε|2dxdt≤C(1+T2),T∈(0,Tmax). |
Proof. We denote
∫Ω∂∂t|∇v|2dx+∫Ω|Δv|2dx=∫Ω∇v⋅∇(wz)dx≤C(∫Ω|∇w|dx+1)≤C(1+t), |
since
Lemma 3.15. There exists a constant
∫T0∫Ω|∇umε|2dxdt≤C(1+T),T∈(0,Tmax). |
Proof. We denote
1m+1ddt∫Ω(u+ε)m+1dx+∫Ω|∇(u+ε)m|2dx≤∫Ωum∇v⋅∇(u+ε)mdx+μ∫Ωuδ(u+ε)mdx−μ∫Ωuδ+1(u+ε)mdx+∫Ω(u+ε)mdx. | (19) |
According to Lemma 3.11 and Lemma 3.12,
∫Ωum∇v⋅∇(u+ε)mdx≤12∫Ω|∇(u+ε)m|2dx+C1, |
where
∫Ω(u+ε)m+1dx+∫T0∫Ω|∇(u+ε)m|2dx≤∫Ω(u0ε+ε)m+1dx+CT. | (20) |
We note that
|∇um|=mum−1|∇u|≤m(u+ε)m−1|∇(u+ε)|=|∇(u+ε)m|. |
This completes the proof.
Lemma 3.16. There exists a constant
∫T0∫Ω|(um+12ε)t|2dxdt+∫Ω|∇umε|2dx≤C(1+T2),T∈(0,Tmax). |
Moreover,
∫T0∫Ω|(umε)t|2dxdt≤4m2(m+1)2‖uε‖m−1L∞(Ω)∫T0∫Ω|(um+12ε)t|2dxdt≤C(1+T2), |
for all
Proof. We denote
∫Ωm(u+ε)m−1|ut|2dx+∫Ω∇(u+ε)m⋅∇[(u+ε)m]tdx≤∫Ωum∇v⋅∇[(u+ε)m]tdx+μ∫Ωuδ[(u+ε)m]tdx−μ∫Ωuδ+1[(u+ε)m]tds+∫Ω|[(u+ε)m]t|dx. | (21) |
We note that
∫Ωμuδ[(u+ε)m]tdx=∫Ωmμuδ(u+ε)m−1utdx≤15∫Ωm(u+ε)m−1|ut|2dx+C1,∫Ω−μuδ+1[(u+ε)m]tdx=−∫Ωmμuδ+1(u+ε)m−1utdx≤15∫Ωm(u+ε)m−1|ut|2dx+C2,∫Ω|[(u+ε)m]t|dx=∫Ωm(u+ε)m−1utdx≤15∫Ωm(u+ε)m−1|ut|2dx+C3, |
where
∫Ωm(u+ε)m−1|ut|2dx=4m(m+1)2∫Ω|((u+ε)m+12)t|2dx, |
and
∫Ω∇(u+ε)m⋅∇[(u+ε)m]tdx=12∂∂t∫Ω|∇(u+ε)m|2dx. |
There holds
∫Ωum∇v⋅∇[(u+ε)m]tdx=−∫Ω[(u+ε)m]t∇⋅(um∇v)dx=−∫Ωm(u+ε)m−1ut⋅(mum−1∇u⋅∇v+umΔv)dx≤15∫Ωm(u+ε)m−1|ut|2dx+C4∫Ω(u+ε)2(m−1)|∇u|2dx+C5∫Ω|Δv|2dx≤15∫Ωm(u+ε)m−1|ut|2dx+C4∫Ω|∇(u+ε)m|2dx+C5∫Ω|Δv|2dx, |
where
∫T0∫Ω|((u+ε)m+12)t|2dxdt+∫Ω|∇(u+ε)m|2dx≤∫Ω|∇(u0ε+ε)m|2dx+C(1+T2)≤C(1+T2). |
Clearly, we have
|(um+12)t|2=(m+1)24um−1|ut|2≤(m+1)24(u+ε)m−1|ut|2=|((u+ε)m+12)t|2, |
and
|(um)t|2≤4m2(m+1)2‖uε‖m−1L∞(Ω)|(um+12)t|2≤4m2(m+1)2‖uε‖m−1L∞(Ω)|((u+ε)m+12)t|2. |
The proof is completed.
Proof of Theorem 3.1. According to the estimates, for any
Now we show the regularity of the globally bounded weak solution.
Lemma 3.17. Let
supt∈R+{‖u‖L∞(Ω)+‖v‖W1,∞(Ω)+‖w‖L∞(Ω)+‖z‖W1,∞(Ω)}≤C. |
Proof. Since
In Lemma 3.13, we have proved
Lemma 3.18. Let
∫Ω|∇w(⋅,t)|pdx≤C(p),t>0, |
for some constant
Proof. This proof proceeds along the idea of the arguments of Lemma 4.3 in [47] and Lemma 4.1 in [40]. Since
w(x,t)=w0(x)e−∫t0z(x,s)ds, |
and
∇w(x,t)=∇w0(x)e−∫t0z(x,s)ds−w0(x)e−∫t0z(x,s)ds∫t0∇z(x,s)ds. |
We see that
|∇w(x,t)|2≤2|∇w0(x)|2e−2∫t0z(x,s)ds+2|w0(x)|2e−2∫t0z(x,s)ds|∫t0∇z(x,s)ds|2. |
And thus
∫Ω|∇w(x,t)|2dx≤C+C∫Ωe−2∫t0z(x,s)ds|∫t0∇z(x,s)ds|2dx≤C−C2∫Ω∇e−2∫t0z(x,s)ds⋅(∫t0∇z(x,s)ds)dx≤C+C2∫Ωe−2∫t0z(x,s)ds⋅(∫t0Δz(x,s)ds)dx≤C+C2∫Ωe−2∫t0z(x,s)ds⋅(∫t0(zt+z−u)ds)dx≤C+C2∫Ωe−2∫t0z(x,s)ds⋅(z(x,t)+∫t0z(x,s)ds)dx≤C. |
Using the same method, we have
|∇w(x,t)|4≤23|∇w0(x)|4e−4∫t0z(x,s)ds+23|w0(x)|4e−4∫t0z(x,s)ds|∫t0∇z(x,s)ds|4, |
and
∫Ω|∇w(x,t)|4dx≤C+C∫Ωe−4∫t0z(x,s)ds|∫t0∇z(x,s)ds|4dx≤C−C4∫Ω∇e−4∫t0z(x,s)ds⋅(∫t0∇z(x,s)ds)3dx≤C+3C4∫Ωe−4∫t0z(x,s)ds⋅(∫t0∇z(x,s)ds)2⋅(∫t0Δz(x,s)ds)dx≤C+3C4∫Ωe−4∫t0z(x,s)ds⋅(∫t0∇z(x,s)ds)2⋅(∫t0(zt+z−u)ds)dx≤C+3C4∫Ωe−4∫t0z(x,s)ds⋅(∫t0∇z(x,s)ds)2⋅(z(x,t)+∫t0z(x,s)ds)dx≤C+3C4∫Ωe−2∫t0z(x,s)ds⋅(∫t0∇z(x,s)ds)2dx⋅supx∈Ω[e−2∫t0z(x,s)ds⋅(z(x,t)+∫t0z(x,s)ds)]≤C, |
according to the proof of the previous estimate on
Proof of Theorem 3.2. Lemma 3.18 shows the uniform bound of
‖w‖Cα(¯Ω×[t,t+1])≤C,t>0. |
Since
‖zt‖Lp(Ω×(t,t+1))+‖Δz‖Lp(Ω×(t,t+1))≤C(p),t>0, |
for some constant
‖z‖Cα(¯Ω×[t,t+1])≤C,t>0. |
Thus,
‖wz‖Cα(¯Ω×[t,t+1])≤C,t>0. |
This can also be deduced by
‖∇(wz)‖Lp(Ω)+‖(wz)t‖Lp(Ω×(t,t+1))≤C,t>0, |
with
‖v‖C2+α,1+α/2(¯Ω×[t,t+1])+‖z‖W2,1p(Ω×(t,t+1))≤C(p). |
The proof is completed.
This section is devoted to the study of the propagating properties of the tumour cells and the large time behavior of the weak solution
We first present the following comparison principle of the first component.
Lemma 4.1. Let
E={u∈L∞(QT);u≥0,∇um∈L2((0,T);L2(Ω)),um−1ut∈L2((0,T);L2(Ω))}, |
{∂u1∂t≥Δum1−∇⋅(um1∇v)+μuδ1(1−u1),∂u2∂t≤Δum2−∇⋅(um2∇v)+μuδ2(1−u2),x∈Ω,t∈(0,T),∂u1∂ν≥0≥∂u2∂ν,x∈∂Ω,t∈(0,T),u1(x,0)≥u2(x,0)≥0,x∈Ω, |
in the sense that the following inequalities
∫T0∫Ωu1φtdxdt+∫Ωu10(x)φ(x,0)dx≤∫T0∫Ω∇um1⋅∇φdxdt−∫T0∫Ωum1∇v⋅∇φdxdt−∫T0∫Ωμuδ1(1−u1)φdxdt,∫T0∫Ωu2φtdxdt+∫Ωu20(x)φ(x,0)dx≥∫T0∫Ω∇um2⋅∇φdxdt−∫T0∫Ωum2∇v⋅∇φdxdt−∫T0∫Ωμuδ2(1−u2)φdxdt, |
hold for some fixed
Proof. The following inequality
∫T0∫Ω(u1−u2)φtdxdt≤∫T0∫Ω∇(um1−um2)⋅∇φdxdt−∫T0∫Ω(um1−um2)∇v⋅∇φdxdt−∫T0∫Ωμ(uδ1(1−u1)−uδ2(1−u2))φdxdt, |
holds for all
a(x,t)={um1−um2u1−u2,u1(x,t)≠u2(x,t),mum−11,u1(x,t)=u2(x,t), |
b(x,t)={(um1−um2)∇vu1−u2,u1(x,t)≠u2(x,t),mum−11∇v,u1(x,t)=u2(x,t), |
and
c(x,t)={μ(uδ1(1−u1)−uδ2(1−u2))u1−u2,u1(x,t)≠u2(x,t),μδuδ−11−μ(δ+1)uδ1,u1(x,t)=u2(x,t). |
Since
∫T0∫Ω(u1−u2)(φt+a(x,t)Δφ+b(x,t)⋅∇φ+c(x,t)φ)dxdt≤0. |
We employ the standard duality proof method or the approximate Hohmgren's approach to complete this proof (see Theorem 6.5 in [43], Chapter 1.3 and 3.2 in [56]). For any smooth function
{φt+(κ+aε(x,t))Δφ+b(x,t)⋅∇φ+cθ(x,t)φ+ψ=0,(x,t)∈QT,∂φ∂ν=0,(x,t)∈∂Ω×(0,T),φ(x,T)=0,x∈Ω, | (22) |
where
cθ(x,t)={μ(uδ1(1−u1)−uδ2(1−u2))u1−u2,|u1(x,t)−u2(x,t)|≥θ,0,|u1(x,t)−u2(x,t)|<θ. |
This definition of
c2θa≤C(θ). |
We may also need to replace
∬QT(u1−u2)ψdxdt≥−∬QT|u1−u2||a−aε||Δφ|dxdt−κ∬QT|u1−u2||Δφ|dxdt−∬QT|u1−u2||c−cθ|φdxdt=:−I1−I2−I3. |
Now we need the a priori estimate on
∬QTφtηΔφdxdt+∬QTη(κ+aε)(Δφ)2dxdt≤∬QTη|b||∇φ||Δφ|dxdt+∬QTηcθφΔφdxdt+∬QTηψΔφdxdt≤∬QTηCa|∇φ||Δφ|dxdt+14∬QTη(κ+aε)(Δφ)2dxdt+∬QTηc2θφ2κ+aεdxdt+∬QTη|∇ψ||∇φ|dxdt≤12∬QTη(κ+aε)(Δφ)2dxdt+∬QTηC2a2|∇φ|2κ+aεdxdt+∬QTηC(θ)φ2dxdt+∬QTη|∇ψ|2dxdt+∬QTη|∇φ|2dxdt. |
Using
∬QTφtηΔφdxdt=−∬QTη∇φ⋅∇φtdxdt=−12∬QTη∂∂t|∇φ|2dxdt≥12∬QTη′(t)|∇φ|2dxdt≥M2∬QT|∇φ|2dxdt. |
Therefore,
(23) |
It follows that
which converges to zero if we let
and
Then there exists a constant
which converges to zero if we first let
which converges to zero if we let
for any given
Here we recall some lemmas about the asymptotic behavior of solutions to evolutionary equations.
Lemma 4.2 ([7]). Let
In particular,
Lemma 4.3 ([47] Lemma 4.1). If
where
Lemma 4.4 ([47] Lemma 4.3, [40] Lemma 4.1). If
with
for all
Now we construct a self similar weak lower solution with expanding support.
Lemma 4.5. Let
where
in the sense that the following inequality
holds for any
Proof. For simplicity, we let
and
Since
for all
provided that
(24) |
In order to find a weak lower solution
(25) |
Since
We denote
(26) |
As we have chosen
(27) |
Let
(28) |
Since
and then
Now, we find a weak lower solution with expanding support and comparison principle Lemma 4.1 implies
There exists a
and thus
Next, we construct another constant lower solution
with
which is valid if we further let
since
This completes the proof.
Remark 3. It is interesting to compare the self similar weak lower solution
with
Proof of Theorem 2.3. This has been proved in Lemma 4.5.
After proving the support expanding property of the first equation in (3), which is a degenerate diffusion equation, we can deduce the following convergence properties of all components.
Lemma 4.6. Let
and
for all
Proof. Applying Lemma 4.3, we see that
since
(29) |
This is also valid for
with
It follows form the second equation in (3) that
and
Using the standard
where
which is the same as the estimate of
is converging to
Therefore,
The proof is completed.
Lemma 4.7. For constants
blows up in finite time if
Proof. There holds
Integrating over
A simple analysis completes this proof.
Lemma 4.8. Let
for all
Proof. Lemma 4.5 implies that
(30) |
Lemma 4.1 shows that
We only need to find one pair of
(31) |
since
Lemma 4.7 implies that
We see that
(32) |
which can be solved as
On the other hand, the lower solution of
We note that we can choose
An ODE comparison shows that
We see that
This can also be solved as
Thus, we conclude
and
Lemma 4.9. Let
for all
Proof. From the fourth equation in (3), we have
We note that
which can be deduced by solving the ODE
The proof is completed.
Proof of Theorem 2.4. This is proved by collecting Lemma 4.5, Lemma 4.6, Lemma 4.8 and Lemma 4.9.
Finally, we construct a self similar upper solution with expanding support to prove Theorem 2.2. We note that for constructing a weak upper solution for the heat equation, one should replace the cut-off composite function
Lemma 4.10. Let
for some
where
in the sense that the following inequality
holds for all test functions
and
Proof. For simplicity, we let
and
Since
for all
(33) |
According to the definition of
provided that
(34) |
In order to find a weak lower solution
(35) |
Since
We denote
(36) |
for all
Let
(37) |
We have the following estimate
for all
(38) |
We note that
Now, we only need to find
This can be done by selecting
The comparison principle Lemma 4.1 implies that
and
which has finite derivative with respect to
Remark 4. Similar to the weak lower solution in Lemma 4.5, we compare the self similar weak upper solution
with
Remark 5. From the proof of Lemma 4.10, we can choose
Proof of Theorem 2.2. This has been proved in Lemma 4.10.
In this section, we extend the derivation of the classical taxis models in [36]. The derivation of the model begins with a master equation for a continuous-time and discrete-space random walk
(39) |
where
Painter and Hillen [11,28] proposed volume filling approach. In this model, the transitional probability then takes the form
(40) |
where
where
Since a different combination of the above strategies may be necessary to reflect cell movement, we combine the local and gradient-based strategies and assume the transitional probability of the form
(41) |
where
A natural choice for
(42) |
which states that the probability of a jump leaving one site increases with the cell density at that site [24,37].
Substituting (41) into the Master Equation (39) gives:
We set
By taking the limit of
where
Apart from that, we consider a modification of the Verhulst logistic growth term to model organ size evolution introduced by Blumberg [2] and Turner [41], which is called hyper-logistic function, accordingly
Including cell kinetics and signal dynamics, we derive the resulting model for the cell movement
Incorporating the kinetic equation of ECM and MDE, we arrive at a modified Chaplain and Lolas' chemotaxis model, see (3), where we assume the constants
The authors would like to express their sincere thanks to two anonymous referees for their valuable comments and suggestions, which led an important and significant improvement of the paper. The research of S. Ji is supported by NSFC Grant No. 11701184. The research of C. Jin was supported in part by NSFC grant No. 11471127, Guangdong Natural Science Funds for Distinguished Young Scholar Grant No. 2015A030306029, the Excellent Young Professors Program of Guangdong Province Grant No. HS2015007, and Special Support Program of Guangdong Province of China. The research of M. Mei was supported in part by NSERC Grant RGPIN 354724-16, and FRQNT Grant No. 192571. The research of J. Yin was supported in part by NSFC Grant No. 11771156.
[1] |
Leitner E, Zarfel G, Luxner J, et al. (2015) Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward. Antimicrob Agents Ch 59: 714-716. doi: 10.1128/AAC.04306-14
![]() |
[2] |
Regev-Yochay G, Smollan G, Tal I, et al. (2018) Sink traps as the source of transmission of OXA-48–producing Serratia marcescens in an intensive care unit. Infect Control Hosp Epidemiol 39: 1307-1315. doi: 10.1017/ice.2018.235
![]() |
[3] |
Donlan RM (2002) Biofilms: microbial life on surfaces. Emerging infect dis 8: 881-890. doi: 10.3201/eid0809.020063
![]() |
[4] |
Tofteland S, Naseer U, Lislevand JH, et al. (2013) A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving intergenus plasmid diffusion and a persisting environmental reservoir. PLoS One 8: e59015. doi: 10.1371/journal.pone.0059015
![]() |
[5] |
Lowe C, Willey B, O'Shaughnessy A, et al. (2012) Outbreak of extended-spectrum β-lactamase-producing Klebsiella oxytoca infections associated with contaminated handwashing sinks (1). Emerging Infect Dis 18: 1242-1247. doi: 10.3201/eid1808.111268
![]() |
[6] |
Carling PC (2018) Wastewater drains: epidemiology and interventions in 23 carbapenem-resistant organism outbreaks. Infect Control Hosp Epidemiol 39: 972-979. doi: 10.1017/ice.2018.138
![]() |
[7] |
Vergara-López S, Domínguez MC, Conejo MC, et al. (2013) Wastewater drainage system as an occult reservoir in a protracted clonal outbreak due to metallo-β-lactamase-producing Klebsiella oxytoca. Clin Microbiol Infect 19: E490-E498. doi: 10.1111/1469-0691.12288
![]() |
[8] |
Stone PW (2009) Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoeconomics Outcomes Res 9: 417-422. doi: 10.1586/erp.09.53
![]() |
[9] |
Al-Tawfiq JA, Tambyah PA (2014) Healthcare associated infections (HAI) perspectives. J Infect Public Health 7: 339-344. doi: 10.1016/j.jiph.2014.04.003
![]() |
[10] |
Logan LK, Weinstein RA (2017) The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215: S28-S36. doi: 10.1093/infdis/jiw282
![]() |
[11] |
Gupta N, Limbago BM, Patel JB, et al. (2011) Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53: 60-67. doi: 10.1093/cid/cir202
![]() |
[12] | Jacob J, Klein E, Laxminarayan R, et al. (2013) Vital signs: carbapenem-resistant enterobacteriaceae. MMWR Morbid Mortal We 62: 165-170. |
[13] |
Kizny Gordon AE, Mathers AJ, Cheong EYL, et al. (2017) The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections—a systematic review of the literature. Clinl Infect Dis 64: 1435-1444. doi: 10.1093/cid/cix132
![]() |
[14] |
De Geyter D, Blommaert L, Verbraeken N, et al. (2017) The sink as a potential source of transmission of carbapenemase-producing Enterobacteriaceae in the intensive care unit. Antimicrob resist infect control 6: 24-24. doi: 10.1186/s13756-017-0182-3
![]() |
[15] |
Roux D, Aubier B, Cochard H, et al. (2013) Contaminated sinks in intensive care units: an underestimated source of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the patient environment. J Hosp Infect 85: 106-111. doi: 10.1016/j.jhin.2013.07.006
![]() |
[16] |
Abedon ST (2017) Active bacteriophage biocontrol and therapy on sub-millimeter scales towards removal of unwanted bacteria from foods and microbiomes. AIMS Microbiol 3: 649-688. doi: 10.3934/microbiol.2017.3.649
![]() |
[17] |
Ramirez K, Cazarez-Montoya C, Lopez-Moreno HS, et al. (2018) Bacteriophage cocktail for biocontrol of Escherichia coli O157:H7: Stability and potential allergenicity study. PLoS One 13: e0195023. doi: 10.1371/journal.pone.0195023
![]() |
[18] |
Lehman SM, Donlan RM (2015) Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrob Agents Ch 59: 1127-1137. doi: 10.1128/AAC.03786-14
![]() |
[19] |
Hughes KA, Sutherland IW, Jones MV (1998) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144: 3039-3047. doi: 10.1099/00221287-144-11-3039
![]() |
[20] |
Azeredo J, Sutherland IW (2008) The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9: 261-266. doi: 10.2174/138920108785161604
![]() |
[21] |
Majkowska-Skrobek G, Latka A, Berisio R, et al. (2018) Phage-borne depolymerases decrease Klebsiella pneumoniae resistance to innate defense mechanisms. Front Microbiol 9: 2517. doi: 10.3389/fmicb.2018.02517
![]() |
[22] |
Fish R, Kutter E, Wheat G, et al. (2016) Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. J Wound Care 25: S27-S33. doi: 10.12968/jowc.2016.25.Sup7.S27
![]() |
[23] |
Mendes JJ, Leandro C, Corte-Real S, et al. (2013) Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 21: 595-603. doi: 10.1111/wrr.12056
![]() |
[24] | Carson L, Gorman SP, Gilmore BF (2010) The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. Pathog Dis 59: 447-455. |
[25] |
Lungren MP, Donlan RM, Kankotia R, et al. (2014) Bacteriophage K antimicrobial-lock technique for treatment of Staphylococcus aureus central venous catheter–related infection: a leporine model efficacy analysis. J Vasc Interv Radiol 25: 1627-1632. doi: 10.1016/j.jvir.2014.06.009
![]() |
[26] |
Mathers AJ, Cox HL, Bonatti H, et al. (2009) Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis 11: 257-265. doi: 10.1111/j.1399-3062.2009.00374.x
![]() |
[27] |
Pierce VM, Simner PJ, Lonsway DR, et al. (2017) Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among enterobacteriaceae. J Clin Microbiol 55: 2321. doi: 10.1128/JCM.00193-17
![]() |
[28] | Adams MH (1959) Bacteriophages London, United Kingdom: Interscience Publishers. |
[29] | O'Toole GA (2011) Microtiter dish biofilm formation assay. J Vis Exp pii: 2437. |
[30] | Donlan RM, Elliot DL, Kapp NJ, et al. (2000) Surfanctants for reducing bacterial adhesion onto surfaces. U.S., Patent, 6039965. editors. |
[31] | Mazher M, Santiago A, Donlan R (2018) Control of Carbapenem-Resistant Klebsiella pneumoniae biofilms using a nonionic surfactant. |
[32] |
Donlan RM, Piede JA, Heyes CD, et al. (2004) Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol 70: 4980-4988. doi: 10.1128/AEM.70.8.4980-4988.2004
![]() |
[33] |
Goeres DM, Loetterle LR, Hamilton MA, et al. (2005) Statistical assessment of a laboratory method for growing biofilms. Microbiology 151: 757-762. doi: 10.1099/mic.0.27709-0
![]() |
[34] |
Armbruster CS, Forster TM, Donlan R, et al. (2012) A biofilm model developed to investigate survival and disinfection of Mycobacterium mucogenicum in potable water. Biofouling 28: 1129-1139. doi: 10.1080/08927014.2012.735231
![]() |
[35] |
Kotay S, Chai W, Guilford W, et al. (2017) Spread from the sink to the patient: in situ study using green fluorescent protein (GFP)-expressing Escherichia coli to model bacterial dispersion from hand-washing sink-trap reservoirs. Appl Environ Microbiol 83: e03327-03316. doi: 10.1128/AEM.03327-16
![]() |
[36] |
Kotsanas D, Wijesooriya WRPLI, Korman TM, et al. (2013) ‘Down the drain’: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 198: 267-269. doi: 10.5694/mja12.11757
![]() |
[37] | Kotay SM, Donlan RM, Ganim C, et al. (2019) Droplet-rather than aerosol-mediated dispersion is the primary mechanism of bacterial transmission from contaminated hand-washing sink traps. Appl Environ Microbiol 85: e01997-01918. |
[38] |
Chan BK, Abedon ST (2015) Bacteriophages and their enzymes in biofilm control. Curr Pharm Design 21: 85-99. doi: 10.2174/1381612820666140905112311
![]() |
[39] |
Cornelissen A, Ceyssens P-J, T'Syen J, et al. (2011) The T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties. PLoS OneE 6: e18597. doi: 10.1371/journal.pone.0018597
![]() |
[40] |
Bodratti AM, Alexandridis P (2018) Formulation of poloxamers for drug delivery. J Funct Biomater 9: 11. doi: 10.3390/jfb9010011
![]() |
[41] |
Pitto-Barry A, Barry NPE (2014) Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polym Chem 5: 3291-3297. doi: 10.1039/C4PY00039K
![]() |
[42] |
Percival SL, Mayer D, Malone M, et al. (2017) Surfactants and their role in wound cleansing and biofilm management. J Wound Care 26: 680-690. doi: 10.12968/jowc.2017.26.11.680
![]() |
[43] |
Das Ghatak P, Mathew-Steiner SS, Pandey P, et al. (2018) A surfactant polymer dressing potentiates antimicrobial efficacy in biofilm disruption. Sci Rep 8: 873-873. doi: 10.1038/s41598-018-19175-7
![]() |
[44] |
Seo Y, Bishop PL (2007) Influence of nonionic surfactant on attached biofilm formation and phenanthrene bioavailability during simulated surfactant enhanced bioremediation. Environ Sci Technol 41: 7107-7113. doi: 10.1021/es0701154
![]() |
[45] |
Simmons M, Drescher K, Nadell CD, et al. (2018) Phage mobility is a core determinant of phage-bacteria coexistence in biofilms. ISME J 12: 531-543. doi: 10.1038/ismej.2017.190
![]() |
[46] |
Tait K, Skillman LC, Sutherland IW (2002) The efficacy of bacteriophage as a method of biofilm eradication. Biofouling 18: 305-311. doi: 10.1080/0892701021000034418
![]() |
[47] |
Baghal Asghari F, Nikaeen M, Mirhendi H (2013) Rapid monitoring of Pseudomonas aeruginosa in hospital water systems: a key priority in prevention of nosocomial infection. FEMS Microbiol Lett 343: 77-81. doi: 10.1111/1574-6968.12132
![]() |
[48] | Cieplak T, Soffer N, Sulakvelidze A, et al. (2018) A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota. Gut Microbes 9: 391-399. |
[49] |
Doolittle MM, Cooney JJ, Caldwell DE (1996) Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol 16: 331-341. doi: 10.1007/BF01570111
![]() |
[50] |
Alexandridis P, Alan Hatton T (1995) Poly (ethylene oxide) poly (propylene oxide) poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloids Surf A 96: 1-46. doi: 10.1016/0927-7757(94)03028-X
![]() |
[51] |
Choi YC, Morgenroth E (2003) Monitoring biofilm detachment under dynamic changes in shear stress using laser-based particle size analysis and mass fractionation. Water Sci Technol 47: 69-76. doi: 10.2166/wst.2003.0284
![]() |
[52] |
Roy B, Ackermann HW, Pandian S, et al. (1993) Biological inactivation of adhering Listeria monocytogenes by listeriaphages and a quaternary ammonium compound. Appl Environ Microbiol 59: 2914-2917. doi: 10.1128/AEM.59.9.2914-2917.1993
![]() |
[53] |
Sillankorva S, Neubauer P, Azeredo J (2010) Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling 26: 567-575. doi: 10.1080/08927014.2010.494251
![]() |
[54] |
Chhibber S, Bansal S, Kaur S (2015) Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and Pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol. Microbiology 161: 1369-1377. doi: 10.1099/mic.0.000104
![]() |
[55] | Lenski RE (1988) Dynamics of Interactions between Bacteria and Virulent Bacteriophage. Advances in microbial ecology Boston, MA: Springer US, 1-44. |
[56] |
Donlan RM (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17: 66-72. doi: 10.1016/j.tim.2008.11.002
![]() |
[57] |
Meaden S, Koskella B (2013) Exploring the risks of phage application in the environment. Front Microbiol 4: 358-358. doi: 10.3389/fmicb.2013.00358
![]() |
[58] |
Colomer-Lluch M, Jofre J, Muniesa M (2011) Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples. PLoS One 6: e17549. doi: 10.1371/journal.pone.0017549
![]() |
[59] |
Nilsson AS (2019) Pharmacological limitations of phage therapy. Upsala J Med Sci 124: 218-227. doi: 10.1080/03009734.2019.1688433
![]() |
[60] |
Wang H, Edwards MA, Falkinham JO, et al. (2013) Probiotic approach to pathogen control in premise plumbing systems? a review. Environ Sci Technol 47: 10117-10128. doi: 10.1021/es402455r
![]() |
[61] |
Camper AK, LeChevallier MW, Broadaway SC, et al. (1985) Growth and persistence of pathogens on granular activated carbon filters. Appl Environ Microbiol 50: 1378. doi: 10.1128/AEM.50.6.1378-1382.1985
![]() |
[62] | Hu YOO, Hugerth LW, Bengtsson C, et al. (2018) Bacteriophages synergize with the gut microbial community to combat Salmonella. mSystems 3: e00119-00118. |
[63] |
Zimlichman E, Henderson D, Tamir O, et al. (2013) Health care–associated Infections: a meta-analysis of costs and financial impact on the US Health Care System. JAMA Int Med 173: 2039-2046. doi: 10.1001/jamainternmed.2013.9763
![]() |
[64] |
Kim BR, Anderson JE, Mueller SA, et al. (2002) Literature review—efficacy of various disinfectants against Legionella in water systems. Water Res 36: 4433-4444. doi: 10.1016/S0043-1354(02)00188-4
![]() |
1. | Tianyuan Xu, Shanming Ji, Ming Mei, Jingxue Yin, On a chemotaxis model with degenerate diffusion: Initial shrinking, eventual smoothness and expanding, 2020, 268, 00220396, 414, 10.1016/j.jde.2019.08.013 | |
2. | Shanming Ji, Ming Mei, Zejia Wang, Dirichlet problem for the Nicholson’s blowflies equation with density-dependent diffusion, 2020, 103, 08939659, 106191, 10.1016/j.aml.2019.106191 | |
3. | Shanming Ji, Zhi-An Wang, Tianyuan Xu, Jingxue Yin, A reducing mechanism on wave speed for chemotaxis systems with degenerate diffusion, 2021, 60, 0944-2669, 10.1007/s00526-021-01990-y | |
4. | Hamid El Bahja, Existence of weak solutions to an anisotropic parabolic–parabolic chemotaxis system, 2023, 0308-2105, 1, 10.1017/prm.2023.18 |